1. Home
  2. PMCB vs ELOG Comparison

PMCB vs ELOG Comparison

Compare PMCB & ELOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.34

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Eastern International Ltd. Ordinary Shares

ELOG

Eastern International Ltd. Ordinary Shares

SELL

Current Price

$1.28

Market Cap

6.4M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
PMCB
ELOG
Founded
1996
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Integrated Freight & Logistics
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.4M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
PMCB
ELOG
Price
$0.34
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
164.1K
★ 650.6K
Earning Date
09-14-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$6.84
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.40
52 Week High
$1.51
$2.83

Technical Indicators

Market Signals
Indicator
PMCB
ELOG
Relative Strength Index (RSI) 33.27 72.51
Support Level $0.33 $0.81
Resistance Level $0.85 $1.31
Average True Range (ATR) 0.03 0.17
MACD -0.00 0.10
Stochastic Oscillator 8.64 69.49

Price Performance

Historical Comparison
PMCB
ELOG

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About ELOG Eastern International Ltd. Ordinary Shares

Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.

Share on Social Networks: